Form 4: Exelixis EVP, Commercial, Patrick J. Haley, Reports Stock Sales and Option Exercise

Patrick J. Haley, EVP, Commercial at Exelixis, Inc., reports multiple transactions involving the company's common stock, including sales, option exercises, and tax-related share withholdings.

Summary

• Patrick J. Haley, EVP, Commercial at Exelixis, filed a Form 4 detailing changes in beneficial ownership of Exelixis stock.
• On May 14, 2025, Haley sold 10,000 shares of common stock at $42.68 per share.
• On May 15, 2025, Haley sold 10,000 shares at $46.95 per share and an additional 116,383 shares at a weighted average price of $48.05.
• Also on May 15, 2025, Haley exercised an option to acquire 116,383 shares at $18.80 per share.
• Exelixis withheld 34,705 shares to cover taxes related to vesting restricted stock units (RSUs).
• Following these transactions, Haley directly owns 446,459 shares and indirectly owns 23,539 shares through his spouse and 10,648 shares through his 401(k).
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 19, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transactions were pre-planned under a 10b5-1 trading plan. It doesn't necessarily reflect a positive or negative outlook on the company's future.

Industry Context

Insider transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. However, transactions under 10b5-1 plans are pre-scheduled and may not reflect current sentiment.

Comparison to Industry Standards

• Comparing Haley's transactions to those of executives at similar-sized biotech companies like Incyte or Vertex Pharmaceuticals would provide a benchmark.
• For example, if executives at Incyte were also selling shares under 10b5-1 plans, it might suggest a broader trend of profit-taking in the sector.
• Conversely, if executives at Vertex were primarily exercising options and holding shares, it could indicate a more bullish outlook for that company.

Stakeholder Impact

• The stock sales could exert downward pressure on the stock price in the short term.
• The transactions provide transparency to shareholders regarding executive compensation and stock ownership.

Key Dates

Keywords

Exelixis, Form 4, insider trading, stock sale, option exercise, beneficial ownership, Haley, EXEL